JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
Global E Online
GLBE
$6.68B
| $23.6M | ﹤0.01% |
1,142,502
+12,441
| +1% | +$282K |
2021 Q2
6 quarters
|
|
1502
iShares US Home Construction ETF
ITB
$2.3B
| $23.6M | ﹤0.01% |
388,730
+380,441
| +4,590% | +$22M |
2013 Q2
38 quarters
|
|
1503
Incyte
INCY
$23.1B
| $23.6M | ﹤0.01% |
293,285
+43,464
| +17% | +$3.33M |
2013 Q2
38 quarters
|
|
1504
PUT
Southern Company
SO
$96.4B
| $23.6M | ﹤0.01% |
329,800
-18,200
| -5% | -$1.22M |
2021 Q2
6 quarters
|
|
1505
PUT
T. Rowe Price
TROW
$22.2B
| $23.5M | ﹤0.01% |
+215,500
| New | +$24.4M |
2022 Q4
0 quarters
|
|
1506
Chegg
CHGG
$81.2M
| $23.5M | ﹤0.01% |
928,747
-27,825
| -3% | -$707K |
2013 Q4
36 quarters
|
|
1507
iShares US Infrastructure ETF
IFRA
$3.98B
| $23.4M | ﹤0.01% |
646,037
+646,015
| +2,936,432% | +$23.1M |
2022 Q2
2 quarters
|
|
1508
FMC
FMC
$1.4B
| $23.4M | ﹤0.01% |
187,664
-470,501
| -71% | -$57.7M |
2013 Q2
38 quarters
|
|
1509
Edgewell Personal Care
EPC
$1.23B
| $23.4M | ﹤0.01% |
606,944
+6,596
| +1% | +$262K |
2013 Q2
38 quarters
|
|
1510
JPMorgan Active Value ETF
JAVA
$6.98B
| $23.2M | ﹤0.01% |
453,828
+35,828
| +9% | +$1.82M |
2021 Q4
4 quarters
|
|
1511
CALL
TSMC
TSM
$2.52T
| $23.2M | ﹤0.01% |
311,800
-97,500
| -24% | -$7.05M |
2020 Q3
9 quarters
|
|
1512
Pultegroup
PHM
$21.7B
| $23.2M | ﹤0.01% |
509,929
-443,598
| -47% | -$18.7M |
2013 Q2
38 quarters
|
|
1513
Intellia Therapeutics
NTLA
$1.79B
| $23.1M | ﹤0.01% |
662,617
+21,770
| +3% | +$1.04M |
2017 Q4
20 quarters
|
|
1514
Fox Class A
FOXA
$26.7B
| $23.1M | ﹤0.01% |
760,413
-191,776
| -20% | -$5.85M |
2019 Q1
15 quarters
|
|
1515
Eastern Bankshares
EBC
$4.86B
| $23.1M | ﹤0.01% |
1,337,795
+211,723
| +19% | +$4.05M |
2020 Q4
8 quarters
|
|
1516
First Bancorp
FBP
$4.14B
| $23.1M | ﹤0.01% |
1,812,271
+80,064
| +5% | +$1.17M |
2013 Q2
38 quarters
|
|
|
ACLX
1517
DELISTED
Arcellx
ACLX
| $23M | ﹤0.01% |
743,998
+590,980
| +386% | +$13.6M |
2022 Q1
3 quarters
|
|
1518
Douglas Emmett
DEI
$1.62B
| $23M | ﹤0.01% |
1,469,669
-2,494,670
| -63% | -$41.5M |
2013 Q2
38 quarters
|
|
1519
Flywire
FLYW
$2.21B
| $23M | ﹤0.01% |
941,406
+45,554
| +5% | +$982K |
2021 Q2
6 quarters
|
|
1520
Owens Corning
OC
$9.29B
| $23M | ﹤0.01% |
269,737
+38,139
| +16% | +$3.34M |
2013 Q2
38 quarters
|
|
1521
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.5B
| $23M | ﹤0.01% |
127,958
+85,184
| +199% | +$15.4M |
2015 Q4
28 quarters
|
|
1522
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
| $23M | ﹤0.01% |
380,514
-47,154
| -11% | -$2.81M |
2017 Q1
23 quarters
|
|
1523
Penumbra
PEN
$12.5B
| $22.9M | ﹤0.01% |
102,844
-1,015
| -1% | -$198K |
2015 Q3
29 quarters
|
|
1524
PUT
Coca-Cola
KO
$372B
| $22.9M | ﹤0.01% |
359,400
+41,000
| +13% | +$2.48M |
2014 Q2
34 quarters
|
|
1525
NovoCure
NVCR
$1.77B
| $22.8M | ﹤0.01% |
310,804
+95,343
| +44% | +$7.17M |
2017 Q4
20 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.